Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Abivax SA (GB:0RA9)
LSE:0RA9
Holding GB:0RA9?
Track your performance easily
0RA9 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€8.15 - €15.18
Previous Close€8.15
Volume0.00
Average Volume (3M)323.00
Market Cap
€534.13M
Enterprise Value€2.45B
Total Cash (Recent Filing)$648.00M
Total Debt (Recent Filing)$2.63B
Price to Earnings (P/E)―
Beta1.57
Next Earnings
Mar 13, 2025EPS Estimate
-€0.65Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.28
Shares OutstandingN/A
10 Day Avg. Volume281
30 Day Avg. Volume323
Standard Deviation0.27
R-Squared0.06
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)6691.30
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.83
Enterprise Value/Gross Profit5.02
Enterprise Value/Ebitda5.03
Forecast
1Y Price Target
€17.60Price Target Upside116.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Abivax SA News
PremiumCompany Announcements
Abivax SA Ends Liquidity Contract, Reports Cash Balance
PremiumCompany Announcements
Abivax Expands Trial for Potential Crohn’s Disease Treatment
PremiumCompany Announcements
Abivax’s Drug Shows Long-Term Efficacy in UC
PremiumCompany Announcements
Abivax Reports Share Capital and Voting Rights
PremiumCompany Announcements
Abivax Reports Share Capital and Voting RightsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.06% Mutual Funds
― Other Institutional Investors
99.58% Public Companies and
Individual Investors
0RA9 FAQ
What was Abivax SA’s price range in the past 12 months?
Abivax SA lowest share price was €8.15 and its highest was €15.18 in the past 12 months.
What is Abivax SA’s market cap?
Currently, no data Available
When is Abivax SA’s upcoming earnings report date?
Abivax SA’s upcoming earnings report date is Mar 13, 2025 which is in 110 days.
How were Abivax SA’s earnings last quarter?
Abivax SA released its earnings results on Nov 07, 2024. The company reported -€0.65 earnings per share for the quarter, the consensus estimate of -€0.65 by €0.
Is Abivax SA overvalued?
According to Wall Street analysts Abivax SA’s price is currently Undervalued.
Does Abivax SA pay dividends?
Abivax SA does not currently pay dividends.
What is Abivax SA’s EPS estimate?
Abivax SA’s EPS estimate is -€0.65.
How many shares outstanding does Abivax SA have?
Abivax SA has 63,294,655 shares outstanding.
What happened to Abivax SA’s price movement after its last earnings report?
Abivax SA reported an EPS of -€0.65 in its last earnings report, expectations of -€0.65. Following the earnings report the stock price went down -2.798%.
Which hedge fund is a major shareholder of Abivax SA?
Currently, no hedge funds are holding shares in GB:0RA9
---
Abivax SA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.52%
12-Months-Change
Fundamentals
Return on Equity
-171.46%
Trailing 12-Months
Asset Growth
66.29%
Trailing 12-Months
Company Description
Abivax SA
Abivax SA is a France based biotechnology company. It is focused on using antiviral technology platform targeting the immune system to eliminate viral diseases. The company's product is ABX 464 which is for treating HIV/AIDS. The antiviral and immunotherapeutic products that the group develops results from three technology platforms; an Antiviral platform, an Immune stimulation platform and a Polyclonal antibody platform. The Antiviral platform targets the formation of Ribonucleoprotein's in the nucleus or the cytoplasm of the infected cell during viral infection, Immune stimulation platform focuses on invariant natural killer agonists and Polyclonal antibodies platform generates neutralizing antibodies against different viruses.
---
0RA9 Stock 12 Month Forecast
Average Price Target
€17.60
▲(116.03% Upside)
Technical Analysis
Best Analysts Covering 0RA9
1 Year
1 Year Success Rate
2/12 ratings generated profit
1 Year Average Return
-17.25%
reiterated a buy rating 2 months ago
Copying Justine Telliez's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -17.25% per trade.
---